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ABSTRACT
Moderate/severe obesity is on the rise in the United States. Weight management includes bariatric surgery, which is effective and can alleviate
morbidity and mortality from obesity-associated diseases. However, many individuals are dealing with nutritional complications. Risk factors
include: 1) preoperative malnutrition (e.g., vitamin D, iron); 2) decreased food intake (due to reduced hunger and increased satiety, food
intolerances, frequent vomiting); 3) inadequate nutrient supplementation (due to poor compliance with multivitamin/multimineral regimen,
insufficient amounts of vitamins and/or minerals in supplements); 4) nutrient malabsorption; and 5) inadequate nutritional support (due to lack of
follow-up, insufficient monitoring, difficulty in recognizing symptoms of deficiency). For some nutrients (e.g., protein, vitamin B-12, vitamin D),
malnutrition issues are reasonably addressed through patient education, routine monitoring, and effective treatment strategies. However, there
is little attention paid to other nutrients (e.g., zinc, copper), which if left untreated may have devastating consequences (e.g., hair loss, poor
immunity, anemia, defects in neuro-muscular function). This review focuses on malnutrition in essential minerals, including calcium (and vitamin
D), iron, zinc, and copper, which commonly occur following popular bariatric procedures. There will be emphasis on the complexities, including
confounding factors, related to screening, recognition of symptoms, and, when available, current recommendations for treatment. There is an
exceptionally high risk of malnutrition in adolescents and pregnant women and their fetuses, who may be vulnerable to problems in growth and
development. More research is required to inform evidence-based recommendations for improving nutritional status following bariatric surgery
and optimizing weight loss, metabolic, and nutritional outcomes. Adv. Nutr. 4: 506–517, 2013.
Introduction
Popularity and Benefits of Bariatric Surgery
Weight loss through bariatric surgery is a popular treatment
for moderate (BMI$35 kg/m2) and severe (BMI$40 kg/m2)
obesity across most higher income countries and in 2011,
>340,000 procedures were performed worldwide (1). In
the United States, a leading country for bariatric surgery, there
were ~160,000 bariatric procedures performed in 2010 (2).
Bariatric surgery was developed in the 1960s and 1970s (3,4),
but its popularity began to increase in 1990 due to the dramatic
rise in severe obesity (5,6), improved safety of the operations
(7), and a consensus statement by the NIH, which offered en-
dorsement and guidance (8). Since 1990, United States data
from the Nationwide Inpatient Sample and the American So-
ciety forMetabolic and Bariatric Surgery estimate that a total of
1,426,268 persons have undergone bariatric surgery (1,9–12).
The burden of severe obesity and comorbid cardio-metabolic
disease, including type 2 diabetes (T2DM)4, atherosclerosis
and cancer, is lifted frommost of these individuals (13–17).
Moreover, decreased prevalence of morbidity, including
athropathy, depression, poor quality of life (18–20), and mor-
tality (21–24), following bariatric surgery is well documented.
Drawbacks of Bariatric Surgery: Nutritional
Complications
Eligibility for bariatric surgery is described by a 1991 NIH
consensus statement and includes individuals who have a
BMI $40 kg/m2 or a BMI $35 kg/m2 and suffer from co-
morbid disease (8). In 2010, the US FDA expanded the cri-
teria for eligibility by approving the use of a device used in
the adjustable banding surgery (described below) for in-
dividuals who have a BMI $30 and have T2DM or other
comorbidities (25). Despite the demonstrated benefits of
bariatric surgery, it remains underutilized by eligible patients
[w1% have undergone surgery (2)] due to lack of accessi-
bility (26), high costs and questionable cost-effectiveness
(27,28), and adverse outcomes that limit acceptability among
patients, doctors, and third-party payers. The major adverse
events relate to the complications of gastrointestinal surgery
that typically occur within 30 d of the procedure and in-
clude wound infection, deep-vein thrombosis, small bowel
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obstructions, abdominal leaks, and death. Severely obese in-
dividuals undergoing major elective surgery are at a high risk
for complications due to preexisting medical conditions (29);
however, due to advances in laparoscopy, which is less inva-
sive and traumatic, the operative mortality and morbidity
has reduced to 0.1–0.3 and 4.5%, respectively, in recent years
(7,30). Despite improvement in perioperative safety, longer
term complications are an important issue for patients under-
going bariatric surgery. These complications can be subdi-
vided into those that are general or gastrointestinal surgery
related (e.g., hernia, bowel obstruction, cholecystitis, slippage
of gastric band/pouch dilation, ulcer, nausea, vomiting, diar-
rhea) (30), nutritional (hypoglycemia, loss of lean body mass,
weight regain, vitamin and mineral deficiencies) (31,32), or
other (e.g., psychosocial issues, neisidioblastosis hyperinsuli-
nemia, bacterial overgrowth) (24,33,34). The frequency of
long-term complications following bariatric surgery is diffi-
cult to ascertain, because this has been mostly determined
through retrospectively obtained data with poor patient
follow-up and the various complications are specific to the
type of surgery performed (14,35). However, as evidenced
by a growing body of case reports, retrospective studies, and
a few prospective studies, poor nutritional outcomes are rel-
atively common after surgery and prevalence of upwards
of 82% has been reported (36–38). Some nutritional com-
plications are well known to the surgeons and other key
practitioners (dietitians, primary care doctors, and endocri-
nologists) who provide postoperative support as well as to
the patients themselves; these include malnutrition in protein,
vitamin B-12, vitamin D, calcium, and iron. Thus, most clin-
ical practices provide adequate patient counseling for preven-
tion and routinely monitor patients for deficiency. However,
for many other nutrients, including B vitamins (thiamine,
pyridoxal phosphate, folate), fat-soluble vitamins (A, K), es-
sential fatty acids, and minerals (zinc, copper), awareness of
risk of deficiency by patients and providers is low and prophy-
lactic protocols and monitoring are insufficient, leading to de-
bilitating consequences including long-term disability (39).
Moreover, as acknowledged by consensus guidelines from
experts within the American Society for Metabolic and
Bariatric Surgery, The Obesity Society and the American
Association of Clinical Endocrinologists, there is need for
more and better quality evidence behind recommendations
for the prevention and treatment for malnutrition after
bariatric surgery (35,40).
The issues of nutritional deficiency following bariatric
surgery were recently comprehensively reviewed (32,35).
However, this present review will focus on the problem of
essential mineral deficiencies following specific surgery pro-
cedures, especially highlighting the complexities involved
in monitoring and risk factors, as well as protocols for pre-
vention and treatment. The issues in recognizing nutritional
complications using clinical signs and symptoms as well as
sensitive biomarkers will be discussed. We discuss the con-
founding issues related to symptoms and biomarkers of defi-
ciency, including the masking of deficiency by other nutrients
and by inflammation. Information is provided regarding
strategies for prophylactic supplementation and interactions
between nutrients that affect absorption and bioavailability.
Finally, we discuss concerns of mineral malnutrition following
bariatric surgery in special populations, namely adolescents
and pregnant women.
Information in this review included published original
articles and review papers that were collected using PubMed
searches containing the subject headings bariatric surgery
(gastric bypass surgery, adjustable gastric banding (AGB),
sleeve gastrectomy (SG), bioliopancreatic diversion) and nu-
tritional deficiencies (malnutrition, micronutrients, nutri-
tional status) published between 1990 and May 2013. The
impact of bariatric surgery on magnesium, phosphorus,
electrolytes (e.g., potassium, sodium, chloride), and trace el-
ements (e.g., selenium, iodine) is important, but the data
were not sufficiently robust to be discussed in the review.
Current Status of Knowledge
Types of Bariatric Surgery Procedures
Bariatric surgeries are defined as procedures that alter the
gastrointestinal tract to reduce caloric intake or absorption
and can be classified by the mechanism of action for pro-
moting weight loss as restrictive or malabsorptive. Restrictive
procedures reduce the volume or capacity of the stomach
and thereby limit caloric intake by promoting early sati-
ety. Malabsorptive procedures reduce the amount of calo-
ries absorbed by altering the flow of food to limit contact
with pancreatic secretions and bile acids and/or bypass
the absorptive regions of the duodenum and proximal jeju-
num. Surgical alteration of the gastrointestine to restrict en-
ergy intake or promote malabsorption of macronutrients is
achieved but with varying effectiveness and durability for
sustained weight loss, as well as resulting nutritional side ef-
fects, depending on the extent of manipulation of the gastro-
intestinal system. The common bariatric surgery procedures
are described herein along with features that may impair nu-
tritional status.
The roux-en-y gastric bypass (RYGB) is the most popular
surgical procedure in the United States at 47% of annual
cases in 2011 (1). RYGB has a dual restrictive and malab-
sorptive mode of action as the stomach is reduced to a vol-
ume of 20–30 mL and stomach contents are rerouted to the
distal jejunum via an anastomosis connection (Fig. 1) (41).
The physiological mechanisms of RYGB for promoting
weight loss are under intense investigation given the acute
resolution of T2DM following surgery (42,43), and potential
mechanisms include caloric restriction and alterations in
secretion of incretins, satiety gastrointestinal hormones, and
bile acids and in the microbiome of the gut (44). Although
malabsorption of proteins and fats occurs after RYGB, restricted
dietary intake plays a much larger role in the reduction of en-
ergy intake (45), and following RYGB, patients dramatically
reduce caloric intake to w1000 kcal/d (46,47). Studies have
shown decreased appetite and increased post-meal satiety
following RYGB, likely due to decreases in ghrelin, an orexi-
genic hormone, and increases in glucagon-like peptide 1 and
polypeptide YY, which are satiety hormones (48–50). However,
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malabsorption may indirectly contribute to the reduction in
dietary intake observed after RYGB. In the remnant stom-
ach pouch, the reduced availability of stomach secretions of
pepsin, rennin, and hydrochloric acid leads to a decreased ca-
pacity for digestion (51). Also, the shunting of undigested
food directly to the lower gut, particularly if high in sim-
ple carbohydrates or fat, can produce an osmotic imbal-
ance that triggers severe gastrointestinal symptoms such as
bloating, nausea, vomiting, flatulence, and diarrhea, known
as dumping syndrome (52). The uncomfortable gastroin-
testinal side-effects of mal-digestion and -absorption may
cause patients to develop food intolerances and avoid nutri-
ent-dense foods such as meat, milk, and high-fiber foods
(53,54). The processes of micronutrient absorption can be
impaired following RYGB, because bioavailability requires
digestive juices and acids in the stomach and small intestine
and because absorption occurs primarily in the duodenum.
Taken together, there are various reasons why RYGB can affect
the status of macro- and micronutrients, including malabsorp-
tion, reduced dietary intake, and avoidance of nutrient-dense
foods.
The AGB procedure has decreased in popularity in recent
years (from 44% in 2008 to 27% in 2011) (1). AGB restricts
intake of food as a band is placed around the proximal stom-
ach, encompassing the upper portion of the fundus and cre-
ating a temporary holding pouch of 30 mL; when food is
ingested, the pouch expands and creates intraluminal pres-
sure and satiety signals are triggered (Fig. 1) (55). An important
feature of this surgery is that the surgeon, or an appropriate
surrogate, is able to periodically tighten the band around
the stomach so that the feeling of fullness is maintained;
without this adjustment, the surgery is ineffective for weight
loss (35,56,57). Nutritional complications related to AGB
occur if the flow of food is obstructed by the narrowness
of the band, which causes reflux, nausea, and/or vomiting.
For this reason, patients tolerate softer foods compared
with foods with a courser texture, leading to an avoidance
of red meats and fibrous fruits and vegetables (54,58,59).
A large study of patients who underwent AGB demonstrated
that two-thirds experience an inability to eat certain
foods and one-third reported regurgitation several times per
week (58). Persistent vomiting following AGB has been
shown to be a major cause of undernutrition following
AGB (60).
The SG is an emerging restrictive procedure that is grow-
ing in popularity, reaching 19% in 2011 (1). The larger cur-
vature of the stomach is dissected, leaving a narrow vertical
tube that can hold a volume of 150 mL, thus similar to AGB,
early satiety is achieved following a small meal (Fig. 1) (61).
Increased satiety may also occur through mechanisms sim-
ilar to those following RYGB, because the appetitive hor-
mone ghrelin is decreased (62,63) and the satiety hormone
PYY is increased following SG (61). Moreover, a decrease
in gastric emptying and small bowel transit time has been
demonstrated after SG, which would limit the digestion and
bioavailability of some nutrients (64). Indeed, poor diet qual-
ity is an expected outcome following SG, because patients ex-
perience difficulties with eating certain foods, as has been
observed following RYGB (54).
The biliopancreatic diversion (BPD) and the more recent
version, the BPD with duodenal switch, are primarily mal-
absorptive surgeries that are highly effective for weight loss
but associated with nutritional complications that are diffi-
cult to treat (65). The popularity of this surgery is low in
the United States (0.8% in 2011) and other countries, but
historical cases exist (1). In the operation, the stomach is re-
sected as is done for the SG (Fig. 1). In fact, SG is derived
from the BPD but without alteration of the intestine (66).
Immediately following exit from the stomach, the food chyme
is diverted and then rejoined with biliary and pancreatic juices
in a common channel that begins at the ileum. Thus, the nu-
tritional consequences of BPD are similar to those encoun-
tered following RYGB but are more severe (67–69) due to
greater malabsorption, particularly of fat and fat-soluble vi-
tamins (70).
Other Factors That Promote Poor Nutritional Status
Following Bariatric Surgery
Candidates for bariatric surgery are often malnourished de-
spite an overconsumption of calories, and obesity is a known
risk factor for nutrient deficiency (71). Mechanisms besides
poor dietary intake explain the association between obesity
and poor nutritional status. The bioavailability of vitamin
D is reduced in the obese state, because vitamin D is seques-
tered in adipose tissue (72,73). Inflammation associated
FIGURE 1 Graphic depiction of bariatric surgery types.
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with obesity induces the production of hepcidin, an acute-
phase protein made in the liver, which blocks iron absorp-
tion in the intestine (74). Also in obesity, hyperinsulinemia
is associated with excessive urinary excretion of zinc, thus
lowering plasma zinc concentrations (75). Assessment of
nutritional status of severely obese patients before bariatric
surgery has revealed varying rates of deficiencies, which is
complicated by the lack of standardization of analytical tests
and different referent ranges that were used. Typically vita-
min D deficiency is high [ranging from 23 to 83%, using
the cutoff of 50 nmol/L (76)] (77–83). Deficiencies in vita-
min B-12, iron, and zinc are not uncommon, ranging from
2 to 18% for vitamin B-12, 1 to 18% for iron, and 12 to 32%
for zinc (77,79–81,84–88). Thus, preexisting nutritional de-
ficiency may put patients undergoing bariatric surgery at
risk for further nutritional complications. Although patients
lose weight after bariatric surgery, many patients experience
inadequate weight loss or weight regain (89,90), so obesity-
induced inflammation may still be an issue following sur-
gery. Following bariatric surgery, expert recommendations
are for a life-long regimen of daily micronutrient supple-
mentation (35). However, compliance with this recommen-
dation is mixed (59,69,91), because some patients: 1) do not
recognize the need; 2) cannot bear the costs; or 3) are misled
or confused by the large variety of commercial supplements,
some of which are incomplete in specific vitamins or min-
erals (81,85). Moreover, many patients do not undergo rou-
tine monitoring for deficiencies and thus the effectiveness of
prophylactic supplementation is not clear (35). Thus, al-
though surgery-induced dietary restriction or malabsorption
is the major factor leading to malnutrition in the bariatric
surgery patient, several nonsurgical factors can further ex-
acerbate the issue.
Malnutrition in Calcium and Vitamin D
Calcium is an essential macromineral, making up to 2% of
the human body, and functions in cell signaling and the
mineralization of bone and teeth (92). Vitamin D is impor-
tant for calcium homeostasis by regulating the absorption of
calcium in the small intestine (93,94). In addition to calcium
metabolism, vitamin D has been implicated in the regulation
of insulin action, immune function, and cell proliferation
(95). Although blood concentration of calcium is often
used as a marker of calcium status, this is not a good indica-
tor because blood concentrations are tightly regulated (92).
Bone represents a storage reservoir of calcium; thus, bone
density, measured by dual X-ray absorptiometry, is better
for assessment of calcium status and reference ranges for
normal healthy individuals have been established using
bone mineral density Z-scores (96). The impact of bariatric
surgery on calcium and vitamin D is complicated, with sur-
gery-induced changes in body weight, dietary intake, and
gut absorption as influential factors. Compared with indi-
viduals of normal weight, obese individuals have higher
bone density due to the positive effect of weight bearing
on bone mineral accretion (97). Weight loss is known to re-
duce bone density, but this may not produce negative effects,
because bone density may remain within the normal range
(98–100). With regards to absorption of calcium and other
divalent metals (iron, copper, zinc) in the gastrointestine,
acidic conditions are required for solubilization and trans-
porters are most prevalent in the duodenum; therefore, de-
creased calcium absorption has been demonstrated after
RYGB (100). Because it is fat soluble, vitamin D absorption
may be decreased as well, although this has not yet been
shown. However, a positive effect of surgery may be the de-
creased amount of body fat available for sequestration of vi-
tamin D or a potential for release of vitamin D from fat
stores during weight loss in the immediate period following
surgery (101). Nevertheless, findings related to vitamin D
status following bariatric surgery, measured by blood con-
centrations of 25-hydroxyvitamin D, have been conflicting,
with decreases following BPD with duodenal switch (69)
and RYGB (101) but an increase (102) or no change
(72,82) reported in other studies. The inconsistency in find-
ings may relate to the large variation in supplementation of
calcium and vitamin D reported in studies of bariatric sur-
gery patients, ranging from doses close to the recommended
dietary allowance to high-dose vitamin D supplementation
(103–105). Despite the equivocal findings for vitamin D,
several studies have shown that bone mineral density decreases
following restrictive (106) and malabsorptive (107–109) sur-
geries due to weight loss and secondary hyperparathyroidism.
However, a 3-y study of women undergoing RYGB demon-
strated that although bone loss occurred, bone mineral density
remained in the normal range and the risk of osteoporosis was
low (109). Some studies have demonstrated that calcium and
vitamin D supplementation may attenuate the risk of bone
loss following bariatric surgery (110,111) and expert recom-
mendations are for daily supplementation of 1200–1500 mg
calcium and at least 3000 international units of vitamin D
(35) (Table 1). More research is needed to determine the
optimum dosages for prophylactic supplementation to avoid
adverse outcomes related to bone as well as nonosseous ef-
fects of calcium and vitamin D. It is also important to deter-
mine the longer term effects of bariatric surgery on calcium
and vitamin D status, as well as bone mineral density, in
growing adolescents.
Malnutrition in Iron
Iron is an essential micromineral in the human body (at
0.005% by weight) and functions in heme and nonheme
proteins involved in oxygen and electron transport. Iron
deficiency is highly prevalent in developing countries but
is also common in industrialized countries, especially in
women of childbearing age (up to 16%) (112). Obesity in-
creases the risk of iron deficiency, which may be explained
by obesity-associated, low-grade inflammation and the in-
duction of hepcidin, which blocks iron absorption proteins
(74). Iron deficiency is therefore prevalent before surgery
and is exacerbated following malabsorptive and restrictive
procedures. In a recent retrospective analysis, the medical
insurance claims of a large population of RYGB patients
(17,930 cases) who had undergone nutritional testing for
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iron deficiency were obtained up to 36 mo following surgery
(113). Although the rate of preoperative testing and postop-
erative follow-up was low (21, 53, 39, and 31% at baseline,
and at 12, 24, and 36 mo following RYGB, respectively),
iron deficiency increased from 5 to 22%. A strength of this
study was the large sample size; a limitation was that the mea-
sures used to define iron deficiency were not specified and
may have included serum iron, which is not sensitive, or se-
rum ferritin, which can be elevated during inflammation, a
common feature of obesity. However, the findings of this
study are consistent with others that show exacerbation of
iron deficiency when followed from before surgery and up
to 60 mo following RYGB, where rates of deficiency between
10 and 45% were reported (77,80,81,86,87,114,115). Although
restrictive procedures, including the SG, are thought to induce
less malabsorption compared with the RYGB, a similar wors-
ening of iron status and increased prevalence of deficiency
(18–24%) following SG surgery has been reported (80,81,113).
However, not all studies have shown a deterioration of iron
status following SG surgery (77). Iron deficiency can occur
without symptoms; however, symptomatic iron deficiency
including anemia and feeling fatigue, cold, and a desire to
eat ice are commonly reported following bariatric surgery
(61,114,116,117).
The complication of iron deficiency post bariatric sur-
gery is difficult to diagnose and treat due to its multifactorial
etiology and because its signs and symptoms, such as ane-
mia, are shared with other nutrient deficiencies (114). Be-
cause of iron loss through menses, premenopausal women
who have bariatric surgery are at increased risk for iron
deficiency. Dietary intake of iron following surgery was re-
ported to be lower than the recommended amount (81),
possibly because patients avoid red meat, a good source of
highly bioavailable heme iron (53). Using stable isotopes,
it was demonstrated that absorption of heme and nonheme
iron was shown to be reduced following RYGB and SG
(118,119), probably due to decreased acidity of the stomach
pouch and bypass of the absorptive regions in the intestine.
Also important is that iron absorption and metabolism are
affected by the availability or status of other nutrients, in-
cluding zinc, vitamin C, and copper. Excess dietary intake
of zinc can compete with iron for absorption (120,121), di-
etary vitamin C enhances the absorption of nonheme iron
(122), and copper is needed for ceruloplasmin, which cata-
lyzes the conversion of Fe2+ to Fe+++ so that it can be trans-
ported by transferrin into circulation (123,124). Regarding
diagnosis, total iron-binding capacity or serum transferrin
receptor are better measures of iron deficiency compared
with serum iron or ferritin; the latter can be elevated in
the inflammatory condition of obesity (125). As suggested
by recent guidelines, for the correct interpretation of anemia
following bariatric surgery, a comprehensive nutritional assess-
ment of iron as well as vitamins B-6 and B-12, folate, copper,
selenium, and zinc is warranted, because anemia can result
from each of these nutrients (35) (Table 1). The interrelated-
ness of iron and other nutrients, especially copper, must be
considered during treatment using iron oral supplementation,
particularly if symptoms persist. Some studies have shown that
supplementation with i.v. iron has been shown to be successful
(80,111), but this needs to be done with caution to prevent
iron overload and in a hospital setting (126).
Malnutrition in Copper
Copper is an essential micromineral that acts as a cofactor in
many enzymes that function in electron transfer. These en-
zymes include cytochrome c oxidase (in the electron trans-
port chain), superoxide dismutase (an antioxidant), amine
oxidases (for synthesis of neurotransmitter norepinephrine),
and lysyl oxidase (involved in collagen crosslinking) (127).
Copper is also needed for iron mobilization in the body;
thus, copper deficiency manifests as iron deficiency, result-
ing in low concentrations of RBCs and white blood cells. Pa-
tients undergoing malabsorptive bariatric surgery are at risk
for impaired copper status due to hypoacidity in the rem-
nant stomach pouch and bypass of the duodenum. Studies
have shown that the concentration of blood copper de-
creases following RYGB (86,128) and BPD (129,130) surgery
and case reports of severe cases of copper deficiency after
these surgeries exist in the literature (131–133). Despite
the lowering of blood copper concentrations that occurs af-
ter malabsorptive surgery, the frequency of copper defi-
ciency after surgery is not clear because copper status is
not commonly assessed. The prevalence of copper deficiency
ranged from 10 to 15% in cross-sectional studies (128,134)
and 4 to 18% (86,128,129) in longitudinal studies. Risk
factors for copper deficiency include RYGB and BPD sur-
gery (128,129) (although there is no data on SG), high zinc
supplementation (135), and insufficient copper in micro-
nutrient supplementation (81,85). The optimum dose of
copper supplementation for prevention of copper deficiency
is not known, but recent guidelines (35) suggest that multi-
vitamin and -mineral supplementation for bariatric surgery
patients contain copper at doses close to the RDA (0.9 mg),
which is not always the case (81,85). Another concern is that
anemia resulting from copper deficiency is often mis-
diagnosed as iron or vitamin B-12 deficiency until serious
neurological symptoms, such as unsteady gait, extremity
numbness, paresthesias, or paralysis, occur that may be irre-
versible (132). Current methods for assessing copper defi-
ciency rely on blood copper and ceruloplasmin, which are
confounded by obesity-induced inflammation (136) and
thus may be falsely elevated during deficiency (Table 1).
Also, care must be taken to use metal-free blood collection
tubes that are commercially available and to avoid environ-
mental contamination when processing (137). Studies in
mice with marginal copper deficiency suggest that the
cupro-protein, copper chaperone for superoxide dismu-
tase in erythrocytes, may be a more sensitive biomarker than
copper and ceruloplasmin, but confirmation is needed in
humans (138).
Malnutrition in Zinc
Zinc is a trace mineral used as a co-factor in a diverse list of
enzymes, including those involved in protein synthesis,
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digestion, immunity, and regulation of gene transcription
(139). Like other divalent cations (iron, copper, calcium),
zinc absorption requires an acidic environment in the stom-
ach and is absorbed in the proximal intestine. Not surpris-
ingly, zinc absorption was demonstrated to have decreased
to 42 and 65% of baseline at 6 and 18 mo after gastric by-
pass surgery, respectively, in a study using stable isotopes
(140). In this study, various markers of zinc status were
used, including plasma zinc, hair zinc, erythrocyte membrane
alkaline phosphatase, erythrocyte metallothionein, and the
exchangeable zinc pool, although the validity of each of
these measures has been questioned (141). Nevertheless, us-
ing these measures, the prevalence of zinc deficiency increased
from preoperative rates of 4–9% to 20–24% at 18 mo follow-
ing surgery. When serum or plasma zinc was used as an indi-
cator, comparable rates of zinc deficiency were reported by
other studies at 24 mo following RYGB (20–35%) and SG
(18–34%) surgeries and higher rates were found following
BPD (74–91%) (80,81,115,129,142). Also zinc deficiency
was found to persist as late as 60 mo following surgery in
SG (12.5%), RYGB (21–33%), and BPD (45%) patients
(81,115,129). Not all studies have found a decrease in blood
concentrations of zinc in patients undergoing malabsorptive
bariatric surgery; Rojas et al. (86) showed substantial increases
in plasma zinc at 6 mo following RYGB. Assessment of zinc
status using systemic zinc concentrations in bariatric surgery
patients may be problematic, because serum zinc is decreased
in states of obesity-induced inflammation (141,143). Also,
zinc is fairly ubiquitous in the environment and care must
be taken not to contaminate samples during assessment; use
of metal-free blood collection tubes is advised (137,144).
Moreover, it is important to determine the importance of ob-
servations of decreased zinc status following bariatric surgery
and the associations with concomitant symptoms of zinc de-
ficiency. Signs and symptoms related to zinc deficiency, in-
cluding hair loss, poor wound healing, and changes in taste
acuity, have been reported in patients after bariatric surgery
(145,146), but these symptoms may not be specific to malnu-
trition in zinc andmay result from deficiencies in other micro-
nutrients, protein, or fatty acids. Like iron, dietary intake of
zinc following bariatric surgery can be lower than the recom-
mended amounts due to avoidance of meat and low compli-
ance with adequate supplementation (142,147). In the study
by Rojas et al. (86), extra zinc supplementation have may pre-
vented undernutrition in zinc that is normally observed fol-
lowing RYGB. However, a caveat with zinc supplementation
is that excess zinc can lead to the sequestration of copper in
gut enterocytes due to zinc-induced upregulation of metallo-
thionein, which binds copper and prevents uptake into the cir-
culation (135). In recognition of this phenomenon, consensus
guidelines recommend that patients undergoing zinc supple-
mentation receive 1 mg of copper for each 8–15 mg of zinc
provided (35) (Table 1). Additional studies are needed to bet-
ter describe zinc deficiency following bariatric surgery, includ-
ing methods for screening that are not confounded by
inflammation, the recognition of signs and symptoms, and ef-
fective strategies for prevention and treatment.
Concerns in Special Populations
Individuals who are eligible for bariatric surgery include ad-
olescents who are in a life stage of growth and development
and there are special concerns regarding the risk of malnutri-
tion in this population. The number of children and teen-
agers undergoing bariatric surgery is currently at 0.13% of
the total number of cases but is expected to increase given
trends in pediatric severe obesity and popularity of bariatric
surgery (30,148,149). Although adolescents experience simi-
lar benefits from bariatric surgery related to metabolic health
and quality of life (150,151), data on nutritional variables fol-
lowing surgery are scare (151–153). Nutritional outcomes to
date are available mostly from patients undergoing AGB or
RYGB surgeries, because the SG is emerging (154,155). The
risk of nutritional complications is high because of preexist-
ing malnutrition in vitamin D (156) [and presumably also in
iron (74)], the increased nutritional requirements of adoles-
cents (147), and compliance issues that may relate to eating
disorders and other psychosocial factors that have been re-
ported in presurgical candidates (157). In teenagers who
have RYGB surgery, poor compliance with the postoperative
dietary and supplementation regimen has been reported
(158). A recent study described the dietary intake and sup-
plement use of adolescents undergoing RYGB and reported
low compliance with recommendations for prophylactic cal-
cium supplementation, so intakes of this nutrient were lower
than recommended (153). In this same study, participants met
or exceeded dietary requirements for intake of folate, iron, and
thiamin and vitamins B-12, E, and D, but biochemical in-
dices of these nutrients were not determined. In a separate
study, bone mineral content decreased by 7.4% in ado-
lescents 24 mo after RYGB, although Z-scores remained
within the normal range. Given the importance of dietary
calcium intake during adolescence for bone health (159,160),
longer studies are needed to monitor and improve the ade-
quacy of calcium and vitamin D in this population. Similarly,
a comprehensive evaluation of other nutrients, especially iron
and zinc, is critically needed in the pediatric population be-
cause of the detrimental impact of bariatric surgery on
these nutrients in adults (32). Consensus guidelines for nu-
tritional support have been developed by experts in pediat-
ric obesity, surgery, and nutrition, incorporating available
data from pediatric and adult literature, and the critical
need for additional evidence-based research was acknowl-
edged (155,161).
The issue of pregnancy following bariatric surgery is two-
sided. On the positive side, bariatric surgery is beneficial for im-
proving reproduction function and fertility (162,163) and also
for decreasing obesity-related maternal complications during
pregnancy, such as gestational diabetes and preeclampsia as
well as macrosomia in the fetus (164,165). Children born to
obese mothers are more susceptible to cardio-metabolic disease
in adulthood due to fetal programming (166). Exciting develop-
ments in this area from studies of genes and other biomarkers
obtained from offspring of women before and after gastric
bypass surgery are that children born after surgery showed
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less predisposition to insulin resistance and other metabolic
pathways (167,168). On the negative side, numerous studies
have found adverse fetal outcomes after bariatric surgery,
such as shorter gestational age, higher risk of being small
for gestational age, and lower birth weight compared with
fetal outcomes from women with similar BMI, age, and par-
ity who had not undergone bariatric surgery (164,169–172).
Some studies have suggested that RYGB leads to worse out-
comes (169) compared with restrictive surgeries, including
AGB, but other studies did not find a difference (173–
175). Adverse fetal outcomes may reflect poor nutritional
status of pregnant women who have had bariatric surgery;
one study found deficiencies in vitamin B-12, folic acid,
iron, and calcium after RYGB (176) and another found higher
rates of anemia in bariatric surgery patients compared with
nonsurgical controls (164). Another study reported that 85%
of women who had undergone bariatric surgery had lower
than recommended intake for calcium (177). Thus, although
bariatric surgery is promoted as a solution for morbidly obese
women who wish to conceive (178), there is a high risk for de-
velopmental problems in the fetus related to deficiencies in iron,
copper, and zinc and other nutrients with long-term conse-
quences on physical and mental function (179).
In conclusion, the benefits of bariatric surgery are tem-
pered by the high frequency of nutritional deficiencies that
occur, some of which are under-recognized and left un-
treated and lead to devastating consequences to bone health
and to the functioning of the immune, nervous, and mus-
cular systems. Bariatric surgery exacerbates preexisting mal-
nutrition in calcium and vitamin D as well as iron due to
reduced bioavailability and malabsorption and poor dietary
intake and compliance with micronutrient supplementa-
tion following surgery. Deficiencies in copper and zinc are
difficult to diagnose, because laboratory assessment may
be confounded by inflammation and signs and symptoms
are shared with deficiencies in other nutrients. These issues
are of great importance, especially in special populations
such as adolescents as well as pregnant women and their fe-
tuses who may be at risk for developmental problems that
affect physical and mental function. Additional research is
needed to establish recommendations for prevention and
treatment to optimize nutritional outcomes following bari-
atric surgery.
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